Insider buying on Oct 10, 2025

On Oct 10, 2025, 7 insiders at 7 companies filed 14 purchases reported on Form 4, worth $15.8M in all, with a median purchase of $5.9K. The largest was Lynx1 Capital Management LP, 10% owner of Cullinan Therapeutics, Inc. (CGEM), who reported buying 626,043 shares worth $4.2M. Officers accounted for 6 purchases, directors who are not officers for 0, and 10% owners with no board or officer role for 7. Chief executives and chief financial officers filed 1 purchase: Draguleasa Mihai, Chief Financial Officer of Rise Gold Corp. (RYES). 1 company showed cluster buying, two or more insiders buying within 7 days: NMZ (2 insiders). For 1 insider of 7, this was the first purchase of that company's stock on our record. That is fewer than the 45 purchases filed on Oct 9, 2025. A Form 4 is due within two business days of the trade, so most of these purchases were made earlier in the week. Code P also covers shares bought privately from the company, so one large figure can be a negotiated placement rather than buying on the exchange.